Your browser doesn't support javascript.
loading
Serum IL6 as a Prognostic Biomarker and IL6R as a Therapeutic Target in Biliary Tract Cancers.
Høgdall, Dan; O'Rourke, Colm J; Dehlendorff, Christian; Larsen, Ole F; Jensen, Lars H; Johansen, Astrid Z; Dang, Hien; Factor, Valentina M; Grunnet, Mie; Mau-Sørensen, Morten; Oliveira, Douglas V N P; Linnemann, Dorte; Boisen, Mogens K; Wang, Xin W; Johansen, Julia S; Andersen, Jesper B.
Afiliação
  • Høgdall D; Department of Oncology, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark. Danhog01@regionh.dk.
  • O'Rourke CJ; Biotech Research and Innovation Centre (BRIC), Department of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Dehlendorff C; Biotech Research and Innovation Centre (BRIC), Department of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Larsen OF; Danish Cancer Society Research Center, Danish Cancer Society, Copenhagen, Denmark.
  • Jensen LH; Department of Oncology, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark.
  • Johansen AZ; Department of Oncology, University Hospital of Southern Denmark, Vejle, Denmark.
  • Dang H; Department of Oncology, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark.
  • Factor VM; Division of Surgical Research, Thomas Jefferson University, Philadelphia, Pennsylvania.
  • Grunnet M; Laboratory of Molecular Pharmacology, Developmental Therapeutics Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland, USA.
  • Mau-Sørensen M; Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
  • Oliveira DVNP; Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
  • Linnemann D; Biotech Research and Innovation Centre (BRIC), Department of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Boisen MK; Department of Pathology, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark.
  • Wang XW; Department of Oncology, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark.
  • Johansen JS; Laboratory of Human Carcinogenesis, Center for Cancer Research, NCI, NIH, Bethesda, Maryland, USA.
  • Andersen JB; Department of Oncology, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark.
Clin Cancer Res ; 26(21): 5655-5667, 2020 11 01.
Article em En | MEDLINE | ID: mdl-32933994

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias do Sistema Biliar / Interleucina-6 / Receptores de Interleucina-6 / Desoxicitidina / Proteína 1 Semelhante à Quitinase-3 Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Aged80 / Animals / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Dinamarca País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias do Sistema Biliar / Interleucina-6 / Receptores de Interleucina-6 / Desoxicitidina / Proteína 1 Semelhante à Quitinase-3 Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Aged80 / Animals / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Dinamarca País de publicação: Estados Unidos